Management of insomnia

New England Journal of Medicine

Volumn 336, Issue 5, 1997, Pages 341-346

  Kupfer, David J ^a   Reynolds III, Charles F ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; ANACIN; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHLORAL HYDRATE; CLONAZEPAM; CLORAZEPATE; CLORAZEPATE DIPOTASSIUM; DIPHENHYDRAMINE; DOXYLAMINE; ESTAZOLAM; HALOPERIDOL; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; MELATONIN; NON PRESCRIPTION DRUG; OXAZEPAM; PARACETAMOL; QUAZEPAM; TEMAZEPAM; TRAZODONE; TRIAZOLAM; TRYPTOPHAN; ZOLPIDEM; ZOLPIDEM TARTRATE;

AMNESIA; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; HUMAN; INSOMNIA; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RELAXATION TRAINING; REVIEW; SLEEP WAKING CYCLE; SOMNOLENCE;

BEHAVIOR THERAPY; HUMANS; HYPNOTICS AND SEDATIVES; PATIENT EDUCATION; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 0031037041     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199701303360506     Document Type: Review

References (50)

1. Gillin JC, Byerley WF. The diagnosis and management of insomnia. N Engl J Med 1990;322:239-48.
2. Nowell PD, Buysse DJ, Morin CM, Reynolds CF III, Kupfer DJ. Effective treatments for selected DSM-IV sleep disorders. In: Gorman J, ed. Psychotherapies and drugs that work: a review of the Outcome Studies. New York: Oxford University Press (in press).
3. Reynolds CF, Regestein Q, Nowell PD, Neylan TC. Diagnosis and treatment of insomnia in the elderly. In: Salzman C, ed. Clinical geriatric psychopharmacology. Baltimore: Williams & Wilkins (in press).
4. Morin CM, Gramling SE. Sleep patterns and aging: comparison of older adults with and without insomnia complaints. Psychol Aging 1989;4: 290-4.
5. Karacan I, Williams RL. Sleep disorders in the elderly. Am Fam Physician 1983;27(3):143-52.
6. Reynolds CF III, Monk TH, Hoch CC, et al. Electroencephalographic sleep in the healthy "old old": a comparison with the "young old" in visually scored and automated measures. J Gerontol Med Sci 1991;46:M39-M46.
7. Dew MA, Reynolds CF III, Monk TH, et al. Psychosocial correlates and sequelae of electroencephalographic sleep in healthy elders. J Gerontol Psychol Sci 1994;49:P8-P18.
8. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA 1989;262: 1479-84.
9. Angst J, Vollrath M, Koch R, Dobler-Mikola A. The Zurich Study. VII. Insomnia: symptoms, classification and prevalence. Eur Arch Psychiatry Clin Neurosci 1989;238:285-93.
10. Vollrath M, Wicki W, Angst J. The Zurich Study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomnia. Eur Arch Psychiatry Clin Neurosci 1989;239:113-24.
11. Mendelson WB. Long-term follow-up of chronic insomnia. Sleep 1995;18:698-701.
12. Ganguli M, Reynolds CF, Gilby JE. Prevalence and persistence of sleep complaints in a rural older community sample: the MoVIES Project. J Am Geriatr Soc 1996;44:778-84.
13. Eaton WE, Badawi M, Melton B. Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry 1995;152:967-72.
14. National Sleep Foundation. Sleep in America: a national survey of U.S. adults. Houston: Gallup Organization, 1991.
15. Drugs and insomnia: NIH Consensus Development Conference. Consensus development conference summary. Vol. 4. No. 10. Bethesda, Md.: National Institutes of Health, 1984:1-9.
16. Diagnostic and statistical manual of mental disorders, 4th ed.: DSM-IV. Washington, D.C.: American Psychiatric Association, 1994.
17. Diagnostic Classification Steering Committee. The international classification of sleep disorders: diagnostic and coding manual. Rochester, Minn.: American Sleep Disorders Association, 1990.
18. Reynolds CF, Buysse DJ, Kupfer DJ. Disordered sleep: developmental and biopsychosocial perspectives on the diagnosis and treatment of persistent insomnia. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995: 1617-29.
19. Strollo PJ Jr, Rogers RM. Obstructive sleep apnea. N Engl J Med 1996;334:99-104.
20. Reite M, Buysse D, Reynolds C, Mendelson W. The use of polysomnography in the evaluation of insomnia. Sleep 1995;18:58-70.
21. Nofzinger EA, Reynolds CF III. Sleep impairment and daytime sleepiness in later life. Am J Psychiatry 1996;153:941-3.
22. Bootzin RR, Perlis ML. Nonpharmacologic treatments of insomnia. J Clin Psychiatry 1992;53:Suppl 6:37-41.
23. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep 1987;10:45-56.
24. Friedman L, Bliwise DL, Yesavage JA, Salom SR. A preliminary study comparing sleep restriction and relaxation treatments for insomnia in older adults. J Gerontol Psychol Sci 1991;46:P1-P8.
25. Hauri P. Treating psychophysiologic insomnia with biofeedback. Arch Gen Psychiatry 1981;38:752-8.
26. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994;151:1172-80.
27. American Hospital Formulary Service Drug Information. Bethesda, Md.: American Society of Health-System Pharmacists, 1996:1536, 1694-718.
28. Garzone PD, Kroboth PD. Pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet 1989;16:337-64.
29. Greenblatt DJ. Pharmacology of benzodiazepine hypnotics. J Clin Psychiatry 1992;53:Suppl 6:7-13.
30. Idem. Benzodiazepine hypnotics: sorting the pharmacokinetic facts. J Clin Psychiatry 1991;52:Suppl 9:4-10.
31. Farney RJ, Walker JM. Office management of common sleep-wake disorders. Med Clin North Am 1995;79:391-414.
32. Bezchlibnuk-Butler KZ, Jefferies JJ, eds. Clinical handbook of psychotropic drugs. 5th ed. Seattle: Hogrefe and Huber, 1995.
33. Crismon ML, Jermain DM. Sleep aid and stimulant products. In: Covington TR, Lawson LC, eds. Handbook of non-prescription drugs. Washington, D.C.: American Pharmaceutical Association, 1993:135-46, 713-4.
34. Aldhous M, Franey C, Wright J, Arendt J. Plasma concentrations of melatonin in man following oral absorption of different preparations. Br J Clin Pharmacol 1985;19:517-21.
35. Dollins AB, Zhdanova IV, Wurtman RJ, Lynch HJ, Deng MH. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci U S A 1995;91:1824-8.
36. MacFarlane JG, Cleghorn JM, Brown GM, Streiner DL. The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: a preliminary study. Biol Psychiatry 1991;30:371-6.
37. Zhdanova IV, Wurtman RJ, Lynch HJ, et al. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995;57:552-8.
38. Hagan RM, Oakly NR. Melatonin comes of age? Trends Pharmacol Sci 1995;16:81-3.
39. Lacy C, Armstrong LL, Ingrim N, Lance LL, eds. Drug information handbook. Hudson, Ohio: Lexi-Comp, 1995.
40. Crismon ML. Insomnia. In: Koda-Kimble MA, Young LY, eds. Applied therapeutics: the clinical use of drugs. 5th ed. Vancouver, Wash.: Applied Therapeutics, 1992;55-1-55-17.
41. Hoehns JD, Perry PJ. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia. Clin Pharmacy 1993;12:814-28. [Erratum, Clin Pharmacy 1993;12:881.]
42. Scharf MB, Roth T, Vogel GW, Walsh JK. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 1994;55:192-9.
43. Shaw SH, Curson H, Coquelin JP. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients. J Int Med Res 1992;20:150-61. [Erratum, J Int Med Res 1992;20:following 494.]
44. Fairweather DB, Kerr JS, Hindmarch I. The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers. Eur J Clin Pharmacol 1992; 43:597-601.
45. Ganzoni E, Santoni JP, Chevillard V, Sébille M, Mathy B. Zolpidem in insomnia: a 3-year post-marketing surveillance study in Switzerland. J Int Med Res 1995;23:61-73.
46. Monti JM, Attali P, Monti D, Zipfel A, de la Giclais B, Morselli PL. Zolpidem and rebound insomnia - a double-blind, controlled polysomnographic study in chronic insomniac patients. Pharmacopsychiatry 1994; 27:166-75.
47. Walsh JK, Engelhardt CL. Trends in the pharmacologic treatment of insomnia [see comments]. J Clin Psychiatry 1992;53:Suppl 12:10-7.
48. Hohagen F, Montero RF, Weiss E, et al. Treatment of primary insomnia with trimipramine: an alternative to benzodiazepinc hypnotics? Eur Arch Psychiatry Clin Neurosci 1994;244:65-72.
49. Sharpley AL, Cowen PJ. Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry 1995;37:85-98.
50. Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995; 346:541-4.